|
 |
lamivudine zidovudineThis page contains recent news articles, when available, and an overview of lamivudine zidovudine but does not offer medical advice. You should contact your physician with regard to any health issues or concerns....the HIV therapy of lamivudine, zidovudine and nevirapine; anti-malarial quinidine; and the antibiotic rifampicin, to treat tuberculosis and leprosy. ... UPI.com Generic Name: Lamivudine/Zidovudine - Nov 11, 2009 Combivir (generic name: Lamivudine/Zidovudine) is used, alone or with other medicines, to slow down the progression of human immunodeficiency virus (HIV) ... Pattaya Daily News Generic Name: Tenofovir, emtricitabine - Nov 11, 2009 Do not take Truvada if you are already taking Atripla, Combivir (lamivudine/zidovudine), Emtriva, Epivir or Epivir-HBV (lamivudine), Epzicom (abacavir ... Pattaya Daily News Coalescing purpuric plaques - Nov 10, 2009 His medications included Combivir (lamivudine/zidovudine) and nelfinavir. A biopsy revealed increased spindle cells with vascular slits. ... Clinical Advisor … approval of co-packaged lamivudine/zidovudine fixed dose combinatio... - Jan 26, 2005 The Food and Drug Administration (FDA) has announced the tentative approval of a co-packaged antiretroviral drug regimen manufactured by Aspen Pharmacare of ... News-Medical.net ABACAVIR, LAMIVUDINE, AND ZIDOVUDINE (Oral route) - a-BAK-a-veer … - May 1, 2007 The three nucleoside analogue combination (abacavir sulfate/lamivudine/zidovudine) is intended only for patients whose regimen would otherwise include these ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com … Efficacy of Abacavir Sulfate/Lamivudine/Zidovudine Alone in... - Oct 12, 2006 SAN FRANCISCO, CA -- October 12, 2006 -- The HIV medication Trizivir(R) (abacavir sulfate, lamivudine, and zidovudine) administered twice daily provides ... DG News FDA Grants Tentative Approval of a Three-Component AIDS Drug - Jul 1, 2006 ..."This new option, a fixed dose combination tablet containing lamivudine, zidovudine, and nevirapine, simplifies the treatment of HIV-1, which is a stumbling ... Kansas City infoZine FDA approves first three-drug fixed-dose tablet for PEPFAR use - Jul 5, 2006 The US Food and Drug Administration (FDA) this week issued the first tentative approval for a three drug, fixed dose tablet for use as a stand-alone ... Aidsmap New and generic drug approvals: Lamivudine/Zidovudine Tablets. - Sep 14, 2006 On 14 Sep 2006, the US Food and Drug Administration announced the tentative approval of ANDA 077411 for Lamivudine/Zidovudine Tablets. ... Pay-Per-View - US Food and Drug Administration News - Factiva, from Dow Jones Resistant HIV in Mother and Infants Reduced With Three-Drug … - Jul 27, 2005 July 27, 2005 (Rio de Janeiro) — Results from a prospective randomized trial in pregnant women who are HIV positive show that adding a combination of ... Medscape India's Strides Arcolab gets FDA nod for two HIV/AIDS new drug … - Jun 6, 2007 MUMBAI (Thomson Financial) - India's Strides Arcolab Ltd said it has received tentative approvals from the US Food and Drug Administration for two new drug ... Forbes Ranbaxy drugs in US AIDS programme under scanner - Sep 24, 2008 MUMBAI: In a new development, the members of the US Committee on Energy and Commerce (USCEC) have asked Secretary of State, Condoleezza Rice, ... Economic Times Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine … - Oct 17, 2007 PRINCETON, NJ and FOSTER CITY, Calif., Oct. 17 /PRNewswire-FirstCall/ -- Bristol-Myers Squibb Company and Gilead Sciences, Inc. announced today that Health ... Free with registration - PR Newswire - AccessMyLibrary.com emtricitabine, tenofovir disoproxil Gilead Sciences clinical data... - Feb 14, 2005 On 3 February 2005 Gilead Sciences announced results from a phase III trial (study 934), which compared tenofovir disoproxil (VIREAD) and emtricitabine ... Pay-Per-View - R & D Focus Drug News - Factiva, from Dow Jones Fixed dose combination tablet simplifies the treatment of HIV-1 - Jul 6, 2006 The recommended regimen for the lamivudine-zidovudine-nevirapine tablet is one pill twice a day following an initial two week treatment with the individual ... RxPG NEWS Bloomberg Printer-Friendly Page - Dec 11, 2007 PRINCETON, NJ and FOSTER CITY, Calif., Dec. 11 /PRNewswire-FirstCall/ -- Bristol-Myers Squibb Company (NYSE: BMY) and Gilead Sciences, Inc. (Nasdaq: GILD) ... Bloomberg International Approvals: Sifrol/Mirapexin and Truvada - Apr 24, 2006 April 24, 2006 — The European Commission has approved a new indication for pramipexole tablets, allowing their use in the once-daily treatment of moderate ... Medscape 144-Week Data From Gilead's Study 934 Comparing Truvada(R) to … - Jul 23, 2007 Gilead Sciences, Inc. (Nasdaq:GILD) today announced the presentation of 144-week data from an ongoing clinical trial, Study 934, comparing a once-daily ... RedOrbit Lamivudine and Zidovudine combination tentatively approved by FDA/ … - Jul 9, 2005 The Food and Drug Administration within the US Department of Health and Human Services (HHS/FDA) today announced the tentative approval of the fixed-dose ... Medical News Today - Medical News Today (press release) 3 Ranbaxy products added to WHO list - Sep 11, 2007 New Delhi, Sept. 10 Ranbaxy Laboratories Ltd has said that three of its products have been added to the World Heath Organisation's (WHO) pre-qualification ... Hindu Business Line FDA Notifications. - Apr 1, 2005 Bristol-Meyers Squibb has issued a "Dear Healthcare Provider" letter regarding important new pharmacokinetic data concerning the coadministration of ... Pay-Per-View - AIDS Alert - Factiva, from Dow Jones References.(THE SELECTION AND USE OF ESSENTIAL MEDICINES) - Jan 1, 2007 ...(1.) WHO Expert Committee on Specifications for Pharmaceutical Preparations. Thirty-ninth report. Geneva, World Health Organization, 2005 (WHO Technical ... Free with registration - Technical Report Series - AccessMyLibrary.com Hydroxyurea (Systemic). - Oct 27, 2005 Hydroxyurea ( hye-DROX-ee-yoo-REE-ah)belongs to the group of medicines called antimetabolites. It is used to treat some kinds of cancer and to prevent ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com Aurobindo Pharma gets USFDA nod for 2 drugs - Dec 31, 2008 PTI. Mumbai: Drug maker Aurobindo Pharma today said it has received approvals from US drug regulator for Stavudine capsules and Stavudine oral solution, ... Livemint Hydroxyurea (Systemic).(Drug overview) - May 1, 2006 Hydroxyurea ( hye-DROX-ee-yoo-REE-ah)belongs to the group of medicines called antimetabolites. It is used to treat some kinds of cancer and to prevent ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com INDONESIA: Trying to solve ARV supply woes - Jul 16, 2008 Reuters and AlertNet are not responsible for the content of this article or for any external internet sites. The views expressed are the author's alone. ... Reuters AlertNet Rwanda to override patents and import cheaper generic AIDS drugs - Jul 20, 2007 GENEVA — Rwanda, where the United Nations estimates that 52 percent of people die before age 40, will become the first government to use global trade rules ... New York Times UPI NewsTrack Health and Science News.(Newswraps) - Jan 26, 2005 COLUMBUS, Ohio, Jan. 26 (UPI) -- Preteen girls need to boost their calcium intake to build bone mass and avoid the brittle bones of osteoporosis in old age, ... Free with registration - UPI NewsTrack - AccessMyLibrary.com Co-packaged AZT/3TC/efavirenz regimen approved for use in PEPFAR … - Mar 9, 2006 The United States' Food and Drug Administration this week granted tentative approval for a co-packaged antiretroviral drug regimen, consisting of ... Aidsmap Market Live from BSE - NSE, Latest Market Commentary | Economic … - Dec 22, 2008 The Bombay Stock Exchange's 30-share Sensex closed at 9928.35, down 171.56 points or 1.70 per cent from the previous day's close. ... Economic Times International Approvals: Atripla, Cubicin, Galvus - Oct 22, 2007 ...to efavirenz plus twice-daily lamivudine/zidovudine ( Combivir, ... discontinuations in the efavirenz plus lamivudine/zidovudine group (9% vs 4%), ... Medscape Multi-component drug delivery system: An emerging trend - Feb 15, 2006 The concept of multi-component therapy is beneficial when the selected agents possess differing mechanisms of action that provide additive or synergistic ... expresspharmapulse.com European Medicines Agency gives first positive opinions on medicinal ... - Nov 20, 2005 The European Medicines Agency today gave, for the first time, a scientific opinion in the context of cooperation with the World Health Organization (WHO) ... Medical News Today - Medical News Today (press release) Antivirals: meeting a world of need: the fight against AIDS requires... - Oct 1, 2005 The whole world wants more antiretroviral medicines (ARVs), particularly fixed-dose combination drugs (FDCs), which are easier for sick people in developing ... Free with registration - Pharmaceutical Executive - AccessMyLibrary.com L'association lamivudine-zidovudine est plus efficace que la poursuite... - May 12, 2006 Staszewski S, Loveday C, Picazo JJ, et al., pour le Lamivudine European HIV Working Group. Safety and efficacy of lamivudine-zidovudine combination therapy ... EBM Journal (Abonnement) GSK withdraws Trizivir patent application 'in public interest' - Oct 10, 2007 Mumbai: British drug maker GlaxoSmithKline Plc. has withdrawn its Indian patent application for its antiretroviral combination drug Trizivir, ... Livemint Abstract and Introduction - Jun 2, 2005 The development and widespread clinical use of coformulated abacavir/lamivudine/zidovudine (ABC/3TC/ZDV) as Trizivir represented an important advance in the ... Medscape The Hindu Business Line - Mar 17, 2006 Aurobindo Pharma Ltd has announced that it has received the first approval for its New Drug Application (NDA) from the US Food and Drug Administration (US ... Hindu Business Line European CHMP Issues Positive Opinion For ATRIPLA(R) (efavirenz 600 … - Oct 19, 2007 Bristol-Myers Squibb Company (NYSE: BMY), Gilead Sciences, Inc. (Nasdaq: GILD) and Merck & Co., Inc. (NYSE: MRK) announced that the Committee for Medicinal ... Medical News Today - Medical News Today (press release) Canadian Drug Company Awarded Rwandan Contract To Provide … - May 13, 2008 Rwanda recently accepted a bid from the Toronto-based generic drug company Apotex to supply its fixed-dose combination antiretroviral drug Apo-triAvir to ... Medical News Today - Medical News Today (press release) Kivexa, One Tablet Once a Day Simplifies Treatment for HIV Patients - Oct 26, 2005 MONTREAL, CANADA -- October 26, 2005 -- Kivexa(TM), a new medication for the treatment of HIV (human immunodeficiency virus) infection from GlaxoSmithKline ... DG News Professional Exposure to Human Immunodeficiency Virus Antibody– … - Jul 19, 2007 The Centers for Disease Control and Prevention, national public health agencies, and an expert committee of the European Commission have recently published ... Archives of Internal Medicine Netherlands Corporate News - Bristol-Myers Squibb en Gilead Sciences ... - Nov 12, 2007 ...( BW)(CA-GILEAD/BRISTOL-MYERS)(GILD)(BMY) Bristol-Myers Squibb and Gilead Sciences Expand Their Alliance to Include Commercialization of ATRIPLA(R) ... Netherlands Corporate News - Netherlands Corporate News (persbericht) FDA tentatively approves Aurobindo's combined HIV regimen.(Food and … - Apr 3, 2006 The US Food and Drug Administration says it has given "tentative approval" to the co-packaging of three antiretrovirals as an initial therapy for HIV/AIDS. ... Free with registration - Pharma Marketletter - AccessMyLibrary.com Four antiretrovirals reduced to three after 48 weeks.(Brief Article) - Jun 24, 2005 A trial started over 400 antiretroviral-naive patients on an intensive 4-drug regimen--Trizivir, (AZT, 3TC, and abacavir) together with Sustiva (efavirenz). ... $4.95 - AIDS Treatment News - ECNext CROI: Treat Mothers to Reduce Breast-Milk HIV Transmission - Feb 6, 2008 By Michael Smith, North American Correspondent, MedPage Today. BOSTON, Feb. 6 -- Giving new mothers highly active antiretroviral therapy (HAART) reduces the ... MedPage Today Clinical Alerts: SPC changes. - Dec 15, 2007 Asasantin Retard capsules (aspirin, dipyridamole) Undesirable effects section updated. Zyprexa range (olanzapine) Fatigue, asthenia and oedema added to side ... Free with registration - Chemist & Druggist - AccessMyLibrary.com HIV/AIDS patients should avoid raw oysters from Pacific NW - Sep 1, 2006 The lamivudine/zidovudine combination is a generic formulation of the approved combination product, Combivir, manufactured by GlaxoSmithKline, ... Pay-Per-View - AIDS Alert - Factiva, from Dow Jones Press Release: AHF Welcomes FDA's First-Ever Approval of Generic … - Jan 25, 2005 AHF Welcomes FDA's First-Ever Approval of Generic AIDS Drugs; US' Largest AIDS Group Urges PEPFAR Officials to Quickly Incorporate Less Costly ARVs Regimens ... Pay-Per-View - PR Newswire - HighBeam Research Aurobindo Pharma Gets Tentative Approval For HIV Drug - Dec 23, 2008 Aurobindo Pharma, an Indian private pharmaceutical company, informed that it has got tentative sanction from US Food & Drug Administration (USFDA) to make ... TopNews Federal Register 2007 - 72 FR 30386 Draft Guidances for Industry … - May 31, 2007 72 FR 30386 Draft Guidances for Industry Describing Product-Specific Bioequivalence Recommendations; Availability May 31, 2007 [Docket No. ... Pay-Per-View - Federal Register 2007 - Loislaw Factiva Search - Dec 4, 2006 Factiva Search 2.0. BETA. Factiva iWorksâ„¢ offers Factiva's exclusive collection of world-class information indexed and optimized for business use. ... Pay-Per-View - US Food and Drug Administration News - Factiva, from Dow Jones International Approvals: Humira, Atripla, Januvia - Jan 14, 2008 January 14, 2008 — The European Commission (EC) has approved adalimumab injection for the treatment of moderate-to-severe plaque psoriasis and ... Medscape Rwanda: Country to Override Copyrights on ARVs - Jul 22, 2007 Kigali — Rwanda will become the first government to use global trade rules to override pharmaceutical patents and import generic drugs. ... AllAfrica.com Drug-resistant HIV puts pressure on industry - Feb 15, 2005 The first documented case of drug resistant HIV has prompted calls to step up HIV drug research after the victim developed full-blown AIDS in just three ... DrugResearcher.com Board Says Stop Experimental Treatment Regimen In HIV Study - May 28, 2008 An independent Data and Safety Monitoring Board (DSMB) has determined that the experimental, once-daily antiretroviral drug regimen of emtricitabine, ... emaxhealth.com Maraviroc: the first CCR5 antagonist for the treatment of HIV.(Focus... - Oct 1, 2007 Maraviroc is the first CCR5 antagonist approved for the treatment of HIV-1 infection. The use of maraviroc is associated with significant decreases in HIV ... $4.95 - Formulary - ECNext Clinical Alerts: SPC changes. - Dec 15, 2007 Asasantin Retard capsules (aspirin, dipyridamole) Undesirable effects section updated. Durogesic DTrans (fentanyl) Details added on use in opioid naove ... $4.95 - Chemist & Druggist - ECNext Article: Rwanda to override AIDS drug patents - International Herald ... - Jul 21, 2007 Rwanda to override AIDS drug patents ... find International Herald Tribune articles. From news reports International Herald Tribune 07-21-2007 Rwanda, ... Pay-Per-View - International Herald Tribune - HighBeam Research FDA CAPSULES - Jul 19, 2005 EYE PROBLEMS PROMPT LABEL CHANGE FOR IMPOTENCE DRUGS. After receiving a small number of post-marketing reportsof sudden vision loss,the Food and Drug ... Pay-Per-View - Newsday - ProQuest Archiver Rwanda: Drug Giant Allows Production of HIV Medication - Aug 9, 2007 Kigali — GlaxoSmithKline PLC (GSK) has said it has given consent to Canadian company Apotex to manufacture a generic fixed dose combination of ... AllAfrica.com Will Budget bring relief to cancer, AIDS patients? - Feb 28, 2006 There could be some relief for patients suffering from cancer and AIDS, if Budget 2006 does indeed slash the different duties on critical drugs for treating ... Hindu Business Line Strides Arcolab receives 1st NDA approval from USFDA - Mar 5, 2007 Mumbai, India: March 5, 2007: Strides Arcolab Ltd. today announced that it has received tentative approval from the United States Food and Drug ... Business Standard Dispatch Online - Your premier Eastern Cape news site - Jan 26, 2005 JOHANNESBURG - Antiretrovirals (ARVs) could cost South Africans as little as R100 a month and local manufacturing of generics could start as early as next ... Dispatch Online Uveitis associated with concurrent administration of rifabutin and... - Oct 26, 2007 A 41-year-old HIV-infected man received lamivudine/zidovudine and nevirapine therapy. He also took isoniazid/rifampicin/pyrazinamide and ethambutol for ... Nature.com The Effect of Globalization of Drug Manufacturing, Production, and … - Nov 9, 2007 Americans benefit from one of the safest drug supplies and one of the highest standards of consumer protection in the world. Over the past decade, though, ... Nature.com FDA Alerts Pharmacists About Mislabeling of HIV Drugs - Apr 11, 2007 By Peggy Peck, Managing Editor, MedPage Today. ROCKVILLE, Md., April 11 -- The FDA and GlaxoSmithKline have warned pharmacies about a drug tampering ... MedPage Today Focus on 2007: a year of novel pharmacologic agents in review.(Focus... - Nov 1, 2007 ...[ILLUSTRATION OMITTED] Many thanks to editorial advisory board members Robert A. Quercia, MS, RPh, and Craig I. Coleman, PharmD, for their valued assistance ... $4.95 - Formulary - ECNext Pharmacology Watch: Reversal of Atherosclerosis Via Intensive Statin ... - May 1, 2006 Aggressive LDL lowering with statins, so-called "very intensive statin therapy," leads to reversal of coronary atherosclerosis, according to a new study. ... Free with registration - Critical Care Alert - AccessMyLibrary.com FDA to allow radio frequency tags in drug labels.(Practice Trends)(Foo... - Jan 1, 2005 ROCKVILLE, MD. -- The Food and Drug Administration has reassured pharmaceutical companies that they can use radio frequency identification technology in ... Free with registration - Clinical Psychiatry News - AccessMyLibrary.com USPHS releases updated guidelines for management of occupational … - Dec 1, 2005 Combivir: tablets containing 300 mg zidovudine and 150 mg lamivudine Zidovudine plus emtricitabine Zidovudine: see above (Emtriva) Emtricitabine: 200-mg ... $4.95 - American Family Physician - ECNext Pharmacology Watch.(intensive statin therapy for reversal of coronary... - May 15, 2006 Aggressive LDL lowering with statins, so-called "very intensive statin therapy," leads to reversal of coronary atherosclerosis, according to a new study. ... Free with registration - Internal Medicine Alert - AccessMyLibrary.com Bartlett HIV/AIDS Review: January 31, 2005: Antiretroviral Drug … - Jan 31, 2005 Panidou ET, Trikalinos TA, Ioannidis JP. Limited benefit of antiretroviral resistance testing in treatment-experienced patients: a meta-analysis. AIDS. ... Medscape БразилиÑ? передает технологию производÑ?тва антиретровируÑ?ны? - Nov 14, 2008 БразилиÑ? намерена оказать помощь Мозамбику в Ñ?троительÑ?тве фармпредприÑ?тиÑ? по производÑ?тву антиретровируÑ?ных лекарÑ?твенных Ñ?редÑ?тв. ... ФармацевтичеÑ?кий веÑ?тник Factiva Search - Jul 12, 2005 Factiva Search 2.0. BETA. Factiva iWorksâ„¢ offers Factiva's exclusive collection of world-class information indexed and optimized for business use. ... Pay-Per-View - Hindustan Times - Factiva, from Dow Jones Netherlands Corporate News - Gilead Sciences meldt derde … - Oct 19, 2007 ...( BW)(CA-GILEAD-SCIENCES)(GILD) Gilead Sciences Announces Third Quarter 2007 Financial Results Business Editors FOSTER CITY, Calif. ... Netherlands Corporate News - Netherlands Corporate News (persbericht) Truvada combo a no go? - Aug 22, 2005 Despite recent disappointments, Gilead Sciences Inc. intends to push forward with the development of a new HIV combination pill joining Gilead's Truvada ... ICIS WTO To Produce Combination Antiretroviral For Rwanda - Oct 9, 2007 The World Trade Organization on Friday announced it had received notification from the Canadian Intellectual Property Office authorizing Toronto-based ... emaxhealth.com 96-Week Data From Gilead's Study 934 Comparing Viread(R) and … - Dec 15, 2006 Gilead Sciences, Inc. (Nasdaq:GILD) today announced the publication of 96-week data from an ongoing clinical trial, Study 934, in the Journal of Acquired ... RedOrbit Netherlands Corporate News - Gilead meldt gegevens overstap van … - Oct 29, 2007 ...( BW)(CA-GILEAD-SCIENCES)(GILD) Gilead Announces 48-Week Data Evaluating Switching from Combivir(R) To Truvada(R) Among Virologically-Suppressed HIV ... Netherlands Corporate News - Netherlands Corporate News (persbericht) HHS/FDA Tentatively Approves Another First-Time Generic AIDS Drug … - Jul 8, 2005 The Food and Drug Administration within the US Department of Health and Human Services (HHS/FDA) today announced the tentative approval of the fixed-dose ... Pay-Per-View - U.S. Food & Drug Administration Documents - Factiva, from Dow Jones WTO Receives Notification From Canada Authorizing Generic Drug … - Oct 10, 2007 The World Trade Organization on Friday announced it had received notification from the Canadian Intellectual Property Office authorizing Toronto-based ... Medical News Today - Medical News Today (press release) Health 24 - News, HIV/Aids - Jul 19, 2005 One day in the lives of two young people in SA: for one it was the best day, but for the other it wa... Merck Sharp & Dohme (MSD) SA (a subsidiary of Merck ... Health24.com Combination HIV Drug Trizivir, Along With Tenofovir, Well Tolerated: ... - Dec 22, 2005 By Paula Moyer. WASHINGTON, DC -- December 22, 2005 -- In the near future, patients with HIV-1 who are taking their first antiretroviral therapy regimen may ... DG News Dysphagia in a HIV patient: concern for the etiology?(Disease/Disorder... - Jan 1, 2007 Abstract: Dysphagia in human immunodeficiency virus (HIV) patients is most commonly of infectious etiology; however, less common causes of esophageal injury ... $4.95 - Southern Medical Journal - ECNext The road forward: industry pioneers have already taken the first... - Mar 1, 2005 In 1999, the world was banging on the industry's door for free AIDS drugs. With one hand, activists pummeled companies' intellectual property, their prices, ... $4.95 - Pharmaceutical Executive - ECNext BRIEFING - ASIA HEALTH - MARCH 13, 2006. - Mar 13, 2006 An executive briefing on Health for March 13, 2006, prepared by Asia Pulse (http://www.asiapulse.com), the real-time, Asia-based wire with exclusive news, ... $4.95 - AsiaPulse News - ECNext HIV/AIDS Therapy; Aurobindo gets US FDA approval for new drug … - Aug 29, 2006 2006 AUG 29 - (NewsRx.com) -- Aurobindo is delighted to share that the company has received the tentative new drug application (NDA) approval for fixed drug ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones FDA approves HIV drug co-package - Apr 19, 2006 The Food and Drug Administration (FDA) has announced the tentative approval of a co-package of three antiretroviral drugs used together to initiate ... DentalPlans.com HIV/AIDS Therapy; Aurobindo gets US FDA approval for new drug … - Aug 28, 2006 2006 AUG 28 - (NewsRx.com) -- Aurobindo is delighted to share that the company has received the tentative new drug application (NDA) approval for fixed drug ... Pay-Per-View - AIDS Weekly - Factiva, from Dow Jones YK Hamied (CMD), Chairman - Sep 1, 2007 Cipla, originally founded as The Chemical, Industrial & Pharmaceutical Laboratories is a prominent Indian pharmaceutical company, best-known outside its ... chemie.de HIV: An ever-changing epidemic. - Aug 10, 2005 London - After years of decreasing numbers of new infections, HIV diagnosis is now increasing again, even in some first world countries. ... $4.95 - M2 Presswire - ECNext AUROBINDO GETS TENTATIVE NOD FROM USFDA FOR FDC ANTI- … - Mar 13, 2006 NEW DELHI, March 13 Asia Pulse - Aurobindo Pharma has received tentative approval from the US Food and Drugs Administration for fixed dose combination (FDC) ... $4.95 - AsiaPulse News - ECNext Press Release: New Research Shows the Use of Fixed Dose … - Apr 12, 2006 New Research Shows the Use of Fixed Dose Combination (FDC) Therapy will Continue to Grow Substantially Exceeding the Growth of Single Pill Alternatives. Pay-Per-View - M2 Presswire - HighBeam Research Localized Mycobacterium avium complex infection of vertebral and … - Feb 1, 2006 Key Words: HIV, immune reconstitution syndrome (IRS), Mycobacterium avium complex (MAC), vertebral osteomyelitis, paravertebral abscess. ... $4.95 - Southern Medical Journal - ECNext HIV/AIDS Therapy; Aurobindo gets US FDA approval for new drug … - Sep 1, 2006 2006 SEP 1 - (NewsRx.com) -- Aurobindo is delighted to share that the company has received the tentative new drug application (NDA) approval for fixed drug ... Pay-Per-View - Drug Week - Factiva, from Dow Jones Access to AIDS medicines stumbles on trade rules: developing countries... - May 1, 2006 Developing countries are failing to make full use of flexibilities built into the World Trade Organization's (WTO) Agreement on Trade-Related Aspects of ... $4.95 - Bulletin of the World Health Organizatio... - ECNext HIV: an ever-changing epidemic - Aug 12, 2005 After years of decreasing numbers of new infections, HIV diagnosis is now increasing again. Ironically, it is the advancements in HIV treatment that are ... Pay-Per-View - Datamonitor News and Comment - Factiva, from Dow Jones Localized Mycobacterium avium complex infection of vertebral and … - Feb 1, 2006 Localized Mycobacterium avium complex infection of vertebral and paravertebral structures in an HIV patient on highly active antiretroviral therapy. Pay-Per-View - Southern Medical Journal - HighBeam Research European Medicines Agency gives first positive opinions on medicinal ... - Nov 28, 2005 The European Medicines Agency today gave, for the first time, a scientific opinion in the context of cooperation with the World Health Organization (WHO) ... Medical News Today - Medical News Today (press release) The Canada Pharmaceuticals And Healthcare Report Provides … - Oct 30, 2007 DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets. com/reports/c72899) has announced the addition of "Canada Pharmaceuticals and ... Free with registration - Business Wire - AccessMyLibrary.com "Stocks on the Rise". - Jan 19, 2006 Wall Street, NYC--Today, wallstreetgrapevine.com, named; Klegg Electronics Inc. (Pink Sheets: KLGE), HS3 Technologies Inc. (OTC BB: HSTT), ... Free with registration - M2 Presswire - AccessMyLibrary.com 96-Week Data from Gilead's Study 934 Comparing Viread(R) and Emtriva … - Aug 14, 2006 TORONTO -- Gilead Sciences, Inc. (Nasdaq:GILD) today announced the presentation of 96-week data from an ongoing clinical trial (Study 934) comparing a ... Free with registration - Business Wire - AccessMyLibrary.com |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |